(Reuters) -Cancer diagnostic firm Caris Life Sciences said on Monday it is targeting a valuation of up to $5.35 billion in ...

Ben Lerer, Lerer Hippeau managing director, joins 'Squawk on the Street' to discuss his outlook for the IPO market what's ...

PDX continues to outperform with strong multi-year returns, Venture Global upside, and a discount to NAV that remains ...